ICR opens new phase I unit in Dallas-Fort Worth area

Wednesday, June 20, 2012 11:49 AM

Independent Clinical Research (ICR) has opened the doors to its two state-of-the-art phase I facilities in the Dallas-Fort Worth area.

The new facilities offers sponsors and CROs two options: a 12-bed facility for small-scale studies or a hospital-based unit with 90+ beds for large-scale studies.

“Today as doctors, we have more treatment options than ever before, but we still need more of these medications. To develop these new medications we are obligated to conduct clinical trials,” said Dr. Khalid Mahmood, president and CEO of ICR. “ICR is excited to play a role in early-stage clinical trials so new drugs and devices can quickly gain FDA approval.

ICR, which has been conducting clinical trials for over 7 years in the Dallas-Fort Worth area, has a highly experienced phase I clinical team that consists of a group of research physicians to serve as Investigators, with each one being a leading expert in their respective therapeutic area.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs